Usefulness of transcatheter arterial embolization (TAE) for large hepatocellular carcinoma using a lecithin-added Lipiodol emulsion

DOI 26 References
  • KOBAYASHI Shinjiro
    Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)
  • OTSUBO Takehito
    Department of Surgery, Institute of Gastroenterology, St Marianna University of Medicine (Kanagawa)
  • KOIZUMI Satoshi
    Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)
  • YOSHITOSHI Kenji
    Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)
  • KATAGIRI Satoshi
    Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)
  • FURUKAWA Tatsuya
    Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)
  • YAMAMOTO Masakazu
    Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)
  • TAKASAKI Ken
    Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University (Tokyo)

Bibliographic Information

Other Title
  • 大型肝細胞癌に対するレシチン加リピオドールエマルジョンを用いた肝動脈塞栓術の有用性

Search this article

Abstract

This study was to retrospectively compare the effectiveness of transarterial embolization (TAE) using a lipidol emulsion for large lesion of hepatocellular carcinoma (HCC). average survival time was retrospectively compared in patients with HCC larger then 3 cm in diameter. Twenty patients were treated with conventional transarterial embolization (TAE)(group A), 27 with transarterial embolization using a lipidol emulsion (TAE-L) (group B). Rates of effectiveness at 3 months and 6 months following treatment were 10.0% and 5.0% in group A and 37.0 and 33.3% in group B respectively (P=0.046, 0.029). The median survival times were 12.0 months in Group A and 23.0 months in Group B (P=0.049).<br>

Journal

References(26)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top